# NYSTATIN AND TRIAMCINOLONE ACETONIDE
> **ANDA207217** · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2017-08-04
## Drug
- **FDA Application Number:** ANDA207217
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Generic name:** Nystatin
- **Active ingredients:** NYSTATIN; TRIAMCINOLONE ACETONIDE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** EPIC PHARMA LLC
- **First approval:** 2017-08-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207217)
---
*AI Analytics · CC0 1.0*